Spironolactone Tablet
Product Images NDC 68071-2989

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 68071-2989). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2989 9)

Pdp (68071 2989 9)
Label for Spironolactone 25 mg oral tablets, pack of 90, labeled by NuCare Pharmaceuticals, Inc. The label includes tablet description as round, white, flat beveled-edge with debossed "SPIT" and "25". The label displays NDC 68071-2989-9, manufacturing and packaging information, and storage instructions to keep at controlled temperature 68-77°F. The product is Rx only.*
FDA Label Image

Figure (Spironolactone Fig1)

Figure (Spironolactone Fig1)
A line graph depicting the probability over time (months) for two groups: Spironolactone (n=822) and Placebo (n=841). The graph shows a comparison of the two groups' probabilities decreasing over a period up to 42 months, with a log-rank p-value < 0.001 indicating statistical significance.*
FDA Label Image

Fig2 (Spironolactone Fig2)

Fig2 (Spironolactone Fig2)
A forest plot displaying hazard ratios (HR) and 95% confidence intervals (CI) comparing spironolactone and placebo effects across various subgroups, including age, sex, race, left ventricular ejection fraction, heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The plot shows subgroup categories on the left and corresponding HR with 95% CI on the right, with a horizontal axis indicating spironolactone benefit to placebo benefit.*
FDA Label Image

Str1 (Spironolactone Str1)

Str1 (Spironolactone Str1)
Chemical structure diagram of spironolactone, showing its steroid-based fused ring system with indicated functional groups including a ketone, a lactone ring, and a thioester.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.